Found: 6
Select item for more details and to access through your institution.
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 67, doi. 10.1177/1753465812438387
- By:
- Publication type:
- Article
Pirfenidone treatment of idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 107, doi. 10.1177/1753465812436663
- By:
- Publication type:
- Article
Long-term respiratory outcome of babies born prematurely.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 115, doi. 10.1177/1753465812436803
- By:
- Publication type:
- Article
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 87, doi. 10.1177/1753465811429478
- By:
- Publication type:
- Article
Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 97, doi. 10.1177/1753465811433579
- By:
- Publication type:
- Article
Rare alpha-1-antitrypsin variants: are they really so rare?
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 2, p. 79, doi. 10.1177/1753465811434320
- By:
- Publication type:
- Article